Company logo

PETQ - PetIQ, Inc.

NASDAQ -> Healthcare -> Drug Manufacturers—Specialty & Generic
Eagle, United States
Type: Equity

PETQ price evolution
PETQ
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jul 2023 31 Mar 2023
Current assets
Cash $116.37 $124.61 $78.44 $25.41
Short term investments
Net receivables $142.51 $151.68 $193.57 $203.32
Inventory $159.31 $128.13 $141.65 $158.09
Total current assets $430.83 $410.66 $422.44 $397.15
Long term investments
Property, plant & equipment $76.18 $75.22 $85.22 $88.32
Goodwill & intangible assets $359.13 $368.84 $373.39 $379.72
Total noncurrent assets $437.39 $446.43 $461.03 $470.56
Total investments
Total assets $868.23 $857.09 $883.47 $867.72
Current liabilities
Accounts payable $139.26 $113.45 $154.14 $150.01
Deferred revenue
Short long term debt $16.2 $14.98 $14.36 $15.09
Total current liabilities $189.53 $164.64 $191.7 $186.19
Long term debt $452.1 $448.61 $451.38 $453.6
Total noncurrent liabilities $455.7 $453.28 $456.16 $458.38
Total debt $468.3 $463.59 $465.74 $468.68
Total liabilities $645.23 $617.92 $647.87 $644.57
Shareholders' equity
Retained earnings -$160.6 -$143.12 -$143.57 -$153.03
Other shareholder equity -$1.71 -$1.72 -$1.99 -$2.27
Total shareholder equity $221.21 $237.18 $233.64 $221.29
(in millions $) 31 Dec 2023 31 Jan 2023 31 Dec 2021 31 Dec 2020
Current assets
Cash $116.37 $101.27 $79.41 $33.46
Short term investments
Net receivables $142.51 $118 $113.95 $102.75
Inventory $159.31 $142.6 $96.44 $97.77
Total current assets $430.83 $370.11 $298.69 $242.3
Long term investments
Property, plant & equipment $76.18 $91.63 $97.1 $83.27
Goodwill & intangible assets $359.13 $355.79 $421.77 $444.16
Total noncurrent assets $437.39 $448.78 $520.9 $529.3
Total investments
Total assets $868.23 $818.9 $819.59 $771.59
Current liabilities
Accounts payable $139.26 $113 $55.06 $68.13
Deferred revenue
Short long term debt $16.2 $15.35 $14.85 $12.68
Total current liabilities $189.53 $149.49 $98.1 $101.07
Long term debt $452.1 $444.18 $465.81 $375.11
Total noncurrent liabilities $455.7 $457.61 $466.26 $376.5
Total debt $468.3 $471.93 $480.66 $387.78
Total liabilities $645.23 $608.97 $564.37 $477.57
Shareholders' equity
Retained earnings -$160.6 -$162.73 -$114.53 -$93.38
Other shareholder equity -$1.71 -$2.22 -$0.68 -$0.69
Total shareholder equity $221.21 $209.92 $252.83 $262.41
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jul 2023 31 Mar 2023
Revenue
Total revenue $219.93 $277.02 $290.47
Cost of revenue $175.94 $204.41 $228.21
Gross Profit $43.99 $72.61 $62.26
Operating activities
Research & development
Selling, general & administrative $42.73 $55.02 $43.33
Total operating expenses $53.93 $63.29 $43.3
Operating income -$9.94 $9.32 $18.96
Income from continuing operations
EBIT -$10.17 $9.31 $18.88
Income tax expense -$1.1 $0.28 $0.45
Interest expense $8.41 $8.58 $8.73
Net income
Net income -$17.49 $0.45 $9.7
Income (for common shares) -$17.49 $0.45 $9.7
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Revenue
Total revenue $1101.96 $921.51 $932.53 $780.05
Cost of revenue $849.22 $711.85 $746.13 $644.86
Gross Profit $252.74 $209.66 $186.39 $135.19
Operating activities
Research & development
Selling, general & administrative $196.24 $182.56 $170.52 $138.38
Total operating expenses $215.83 $229.69 $168.6 $137.8
Operating income $36.91 -$20.03 $17.79 -$2.62
Income from continuing operations
EBIT $36.51 -$19.62 $12.6 $1.04
Income tax expense -$0.17 $1.21 $3.87 $52.22
Interest expense $34.55 $27.37 $24.7 $26.3
Net income
Net income $2.13 -$48.21 -$15.97 -$77.47
Income (for common shares) $2.13 -$48.21 -$15.97 -$77.47
(in millions $) 31 Dec 2023 30 Sep 2023 30 Jun 2023 31 Mar 2023
Net income -$17.49 $0.45 $9.47 $9.7
Operating activities
Depreciation $8.68 $16.05 $11.31 $8.46
Business acquisitions & disposals -$27.63
Stock-based compensation $1.41 $2.85 $2.74 $2.47
Total cash flows from operations -$2.84 $50.33 $57.73 -$43.33
Investing activities
Capital expenditures -$2.94 -$2.08 -$2.22 -$1.91
Investments
Total cash flows from investing -$2.94 -$2.08 -$2.22 -$29.54
Financing activities
Dividends paid
Sale and purchase of stock $0.05
Net borrowings -$2.26 -$2.24 -$2.35 -$2.25
Total cash flows from financing -$2.37 -$2.25 -$2.48 -$3.09
Effect of exchange rate -$0.1 $0.18 -$0 $0.1
Change in cash and equivalents -$8.15 $46 $53.03 -$75.96
(in millions $) 31 Dec 2023 31 Dec 2022 31 Dec 2021 31 Dec 2020
Net income $2.13 -$48.21 -$15.97 -$77.47
Operating activities
Depreciation $44.5 $35.47 $39.3 $30.98
Business acquisitions & disposals -$27.63 -$96.07
Stock-based compensation $9.47 $11.36 $9.43 $9.17
Total cash flows from operations $61.89 $48.02 $23.77 -$4.6
Investing activities
Capital expenditures -$9.14 -$11.97 -$26.14 -$21.95
Investments
Total cash flows from investing -$36.78 -$11.97 -$26.14 -$118.02
Financing activities
Dividends paid
Sale and purchase of stock $0.05 -$3.74 $13.43 $9.27
Net borrowings -$9.09 -$9.09 $43.57 $135.5
Total cash flows from financing -$10.19 -$13.71 $48.33 $128.76
Effect of exchange rate $0.18 -$0.48 -$0.01 $0.04
Change in cash and equivalents $14.92 $22.34 $45.96 $6.14
Fundamentals
Market cap $537.94M
Enterprise value $889.88M
Shares outstanding 29.43M
Revenue N/A
EBITDA N/A
EBIT N/A
Net Income N/A
Revenue Q/Q 19.47%
Revenue Y/Y N/A
P/E ratio N/A
EV/Sales N/A
EV/EBITDA N/A
EV/EBIT N/A
P/S ratio N/A
P/B ratio 2.41
Book/Share 7.58
Cash/Share 3.95
EPS N/A
ROA N/A
ROE N/A
Debt/Equity 2.92
Net debt/EBITDA N/A
Current ratio 2.27
Quick ratio 1.43